AI assistant
Sending…
Captor Therapeutics S.A. — Director's Dealing 2026
Feb 26, 2026
5552_rns_2026-02-26_62bd4530-e77f-4bdf-9553-3dff3f90814e.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Notification on transaction/transactions* referred to
in Article 19(1) of MAR
| 1 | Data of the person discharging managerial responsibilities / person closely associated with such person | ||
|---|---|---|---|
| a) | Entity name/Last name | Sylvain Cottens | |
| 2 | Reason for submitting the notification | ||
| a) | Job title/status | SVP Chemistry | |
| b) | Original notification / change | Original notification | |
| 3 | Data of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Entity name | "CAPTOR THERAPEUTICS" SPÓŁKA AKCYJNA | |
| b) | LEI | 259400JHH1S2I2S4O735 | |
| 4 | Details of the transaction: please fill in this field for (i) each instrument type; (ii) each transaction type; (iii) each date; and (iv) each trading venue | ||
| a) | Description of the financial instrument, instrument type Identification code | Common shares ISIN: PLCPTRT00014 | |
| b) | Transaction type | Acquisition | |
| c) | Price and volume | Price | Volume |
| 81,4 PLN | 28 | ||
| 81,6 PLN | 120 | ||
| 81,8 PLN | 607 | ||
| 82 PLN | 345 | ||
| d) | Aggregate information - Total volume - Price | 1100 | |
| 81,83 PLN | |||
| e) | Transaction date | 2026-02-26 | |
| f) | Trading venue | XWAR – Warsaw Stock Exchange/Equities/Main Market |
- Delete as appropriate
More from Captor Therapeutics S.A.
Interim / Quarterly Report
2026
May 27
Interim / Quarterly Report
2026
May 27
Proxy Solicitation & Information Statement
2026
May 22
Proxy Solicitation & Information Statement
2026
May 22
Proxy Solicitation & Information Statement
2026
May 22
Governance Information
2026
May 22
Audit Report / Information
2026
May 22
Remuneration Information
2026
May 22
Proxy Solicitation & Information Statement
2026
May 22
Proxy Solicitation & Information Statement
2026
May 22